Spread of triple-negative breast cancer could be halted with existing drug
from Medical News Today
A class of drugs already approved for the treatment of estrogen receptor-positive breast cancer may also have the potential to halt the spread of hard-to-treat, triple-negative breast cancer, a new study finds. Published in the journal Nature Communications, the study reveals that drugs that block an enzyme pathway called CDK 4/6 — known as CDK 4/6 inhibitors — prevented the spread of triple-negative breast cancer in a number of models.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063